Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Terbinafine quickly builds up in skin and hair, staying effective for over 3 weeks.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The research identified various cell types in mouse and human teeth, which could help in developing dental regenerative treatments.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Wnt and Notch signaling help wound healing by promoting cell growth and regulating cell differentiation.

Finasteride may cause long-lasting sexual side effects.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

New treatments targeting specific genes show promise for treating keratin disorders.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.